Wedbush raises Rubrik target price to $150 from $120
RBRK•Wedbush raised its target price for Rubrik to $150 from $120.
Related News
CEECAT Capital completes sale of Hermann Müller Medizintechnik to STERIS
STE•
Braskem, creditors remain at odds over debt restructuring terms
BAK•
Xtend reports preliminary third-quarter 2026 results, names Matt McGraw U.S. CEO and issues shareholder letter
XTND•
Aptevo Therapeutics mipletamig combination enabled 21% of frontline AML patients to advance to stem cell transplant
APVO•
AAR increases revolving credit facility by $550 million
AIR•